| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||





* Department of Pharmacology,
Department of Medicine and Bioregulatory Science, and ¶ Division of Pathophysiological and Experimental Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;
Department of Pharmacology, University of Oxford, Oxford, United Kingdom; and
Laboratory of Biosignals and Response, Graduate School of Biostudies, Kyoto University, Kyoto, Japan
Correspondence: Address reprint requests to Noriyoshi Teramoto, Tel.: 81-92-642-6077; E-mail: noritera{at}med.kyushu-u.ac.jp.
The biological and molecular properties of tetrodotoxin (TTX)-sensitive voltage-gated Na+ currents (INa) in murine vas deferens myocytes were investigated using patch-clamp techniques and molecular biological analyses. In whole-cell configuration, a fast, transient inward current was evoked in the presence of Cd2+, and was abolished by TTX (Kd = 11.2 nM), mibefradil (Kd = 3.3 µM), and external replacement of Na+ with monovalent cations (TEA+, Tris+, and NMDG+). The fast transient inward current was enhanced by veratridine, an activator of voltage-gated Na+ channels, suggesting that the fast transient inward current was a TTX-sensitive INa. The values for half-maximal (Vhalf) inactivation and activation of INa were –46.3 mV and –26.0 mV, respectively. RT-PCR analysis revealed the expression of Scn1a, 2a, and 8a transcripts. The Scn8a transcript and the
-subunit protein of NaV1.6 were detected in smooth muscle layers. Using NaV1.6-null mice (NaV1.6–/–) lacking the expression of the Na+ channel gene, Scn8a, INa were not detected in dispersed smooth muscle cells from the vas deferens, while TTX-sensitive INa were recorded in their wild-type (NaV1.6+/+) littermates. This study demonstrates that the molecular identity of the voltage-gated Na+ channels responsible for the TTX-sensitive INa in murine vas deferens myocytes is primarily NaV1.6.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |